ArticleJournal of the Society for Cardiovascular Angiography & Interventions2026
Early Clinical Experience With CrossFAST, a Novel, Microcatheter-Led Delivery System for Complex Percutaneous Coronary Intervention.
Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Guide extension catheters are integral to coronary intervention. First-generation guide catheter extension devices are monorail, blunt-ended tubular structures with limitations. CrossFAST (Vantis Vascular) is a next-generation, microcatheter-led advanced device delivery system intended to allow safe, deep coronary intubation to assist in complex percutaneous coronary intervention. Methods: The CrossFAST device delivery system was FDA 510(k) cleared in December 2024. We describe this new technology and review 4 of the early clinical cases utilizing CrossFAST to assist in complex percutaneous coronary intervention. Results: The CrossFAST system was used successfully to assist in-stent delivery in all 4 of these cases: Distal right coronary artery, proximal plus mid left circumflex, mid left anterior descending, and proximal diagonal. The device crossed the target lesion in all cases, allowing seamless stent delivery without complications after conventional attempts, including guide extension catheters, had failed. Conclusions: The CrossFAST was used successfully in the treatment of these 4 complex, calcific, coronary artery disease cases, to assist in coronary device delivery and placement. Additional data will be needed to further evaluate the safety and efficacy of this technology as compared to conventional approaches to complex coronary artery disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.